BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27461215)

  • 1. Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
    Neven E; Opdebeeck B; De Maré A; Bashir-Dar R; Dams G; Marynissen R; Behets GJ; Verhulst A; Riser BL; D'Haese PC
    Calcif Tissue Int; 2016 Nov; 99(5):525-534. PubMed ID: 27461215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
    De Schutter TM; Behets GJ; Geryl H; Peter ME; Steppan S; Gundlach K; Passlick-Deetjen J; D'Haese PC; Neven E
    Kidney Int; 2013 Jun; 83(6):1109-17. PubMed ID: 23486515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
    de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
    Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.
    de Oliveira RB; Louvet L; Riser BL; Barreto FC; Benchitrit J; Rezg R; Poirot S; Jorgetti V; Drüeke TB; Massy ZA
    Calcif Tissue Int; 2015 Aug; 97(2):179-92. PubMed ID: 26087714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification.
    Finch JL; Lee DH; Liapis H; Ritter C; Zhang S; Suarez E; Ferder L; Slatopolsky E
    Kidney Int; 2013 Dec; 84(6):1145-53. PubMed ID: 24107846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
    Russo D; Bellasi A; Pota A; Russo L; Di Iorio B
    J Nephrol; 2015 Feb; 28(1):73-80. PubMed ID: 24599830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
    Terai K; Nara H; Takakura K; Mizukami K; Sanagi M; Fukushima S; Fujimori A; Itoh H; Okada M
    Br J Pharmacol; 2009 Apr; 156(8):1267-78. PubMed ID: 19302594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease.
    Barreto FC; de Oliveira RB; Benchitrit J; Louvet L; Rezg R; Poirot S; Jorgetti V; Drüeke TB; Riser BL; Massy ZA
    J Bone Miner Metab; 2014 Nov; 32(6):636-44. PubMed ID: 24442863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
    Neven E; Bashir-Dar R; Dams G; Behets GJ; Verhulst A; Elseviers M; D'Haese PC
    J Bone Miner Res; 2015 Dec; 30(12):2313-24. PubMed ID: 26108730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
    Phan O; Maillard M; Malluche HH; Stehle JC; Funk F; Burnier M
    Biomed Res Int; 2015; 2015():515606. PubMed ID: 26221597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of phosphate binders on vascular calcification].
    Hanafusa N
    Clin Calcium; 2015 May; 25(5):711-21. PubMed ID: 25926575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with tenapanor and sevelamer synergistically reduces urinary phosphorus excretion in rats.
    King AJ; Kohler J; Fung C; Jiang Z; Quach A; Kumaraswamy P; Chertow GM; Rosenbaum DP
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F133-F144. PubMed ID: 33283643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease.
    Mason DL; Godugu K; Nnani D; Mousa SA
    Clin Transl Sci; 2022 Feb; 15(2):353-360. PubMed ID: 34599865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pyrophosphate in vascular calcification in chronic kidney disease.
    Azpiazu D; Gonzalo S; González-Parra E; Egido J; Villa-Bellosta R
    Nefrologia (Engl Ed); 2018; 38(3):250-257. PubMed ID: 29137892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
    Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
    Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
    Ishiwata R; Morimoto Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166323. PubMed ID: 34921974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
    Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.